Neuroimmune Mechanisms in the Treatment of Multiple Sclerosis
Author:
Lechtenberg Richard
Reference24 articles.
1. Wada, H., Inagaki, N., Yamatodani, A., and Watanabe, T. (1991) Trends Neurosci. 14, 415 - 422. 2. McCormick, D. A. and Williamson, A. (1991) J. Neurosci.
11, 3188 - 3197. 3. Eitan, S. and Schwartz, M. (1993) A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science
261, 106 - 108. 4. Gallo, P., Piccinno, M. G., Tavolato, B., and Siden, A. (1991) A longitudinal study of IL-2, sIL-2R, IL-4 and IFN-gamma in multiple sclerosis. J. Neurol. Sci.
101, 227 - 232. 5. Trotter, J. L., Collins, K. G., and van der Veen, R. C. (1991) Serum cytokine levels in chronic progressive multiple sclerosis: interleukin-2 levels parallel tumor necrosis factor-alpha levels. J. Neuroimmunol.
33, 29 - 36.
|
|